Skip to main content
. 2014 Jun;88(12):7054–7069. doi: 10.1128/JVI.00704-14

FIG 10.

FIG 10

CPSF6-358 inhibition of nuclear entry, DBR1 shRNA inhibition, and subcellular localization of reverse transcription products. HeLa.LPCX (HeLa) and HeLa.LPCX-HA-CPSF6-358 (CPSF6-358) cells were transfected with D4 for 48 h, followed by infection with a DNase-treated HIV-1 vector (HR-E). The analysis was the same as that described in the legend to Fig. 9.